Platinum chemotherapy: carboplatin or cisplatin

Phase 2

00%

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

Upcoming Catalysts

12mo

GNLXPhase 2$107M

Platinum chemotherapy: carboplatin or cisplatin Phase 2 Results Expected

Platinum chemotherapy: carboplatin or cisplatin• Advanced Non-squamous Non-small-cell Lung Cancer142

Feb 15Estimated

00%

Competitive Landscape

0 competitors in Advanced Non-squamous Non-small-cell Lung Cancer

Drug Information

Target Indication

Advanced Non-squamous Non-small-cell Lung Cancer

Clinical Trial

Last updated: 2/13/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

GNLX

GENELUX Corp

Related Pipeline

Platinum-resistant Ovarian Cancer

Peritoneal Carcinomatosis